GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Daclatasvir and Sofosbuvir Tablets 60mg/400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Daclatasvir and Sofosbuvir Tablets 60mg/400mg
Each film-coated tablet contains:
Daclatasvir Dihydrochloride IP
Eq. to Daclatasvir …………………….60mg
Sofosbuvir ……………………………….400mg
Colour: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.

CAUTION & SHEDULE:

CAUTION: Do not use if seal over bottle opening is broken or missing. Dispense in a tight, light-resistance, container.
Keep store in tightly closed container.
DO NOT BREAK OR CRUSH TABLET
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a “Gastroenterologists/Hepatologist Only”

STORAGE & DOSAGE:

STORAGE: Store below 30°C. Preserve in tight container. Keep in cool & Dry place. Protect from Light.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Read enclosed leaflet before use
DOSAGE: AS Directed by The Physician

Daclatasvir and Sofosbuvir Tablets 60mg/400mg Technical Specification

Product Name:Daclatasvir and Sofosbuvir Tablets 60mg/400mg
Brand Name:Generic
Strength:60mg/400mg
Dosage Form:Film-coated Oral Tablets
Route of Administration:Via Oral Route
Packing:28s
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Treatment of Chronic hepatitis C
Indication: Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors
Storage:Store below 30°C. Preserve in tight container. Keep in cool
& Dry place. Protect from Light.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Daclatasvir and Sofosbuvir Tablets 60mg/400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION: 

  • Daclatasvir and Sofosbuvir Tablets 60mg/400mg
    Each film-coated tablet contains:

    Daclatasvir Dihydrochloride IP
    Eq. to Daclatasvir …………………….60mg
    Sofosbuvir ……………………………….400mg
    Colour: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.

CAUTION & SHEDULE:

CAUTION:  Do not use if seal over bottle opening is broken or missing.
Dispense in a tight, light-resistance, container.
Keep store in tightly closed container.
DO NOT BREAK OR CRUSH TABLET

SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of a “Gastroenterologists/Hepatologist Only”

STORAGE & DOSAGE:

STORAGE: Store below 30°C. Preserve in tight container. Keep in cool & Dry place. Protect from Light.
Keep medicine out of reach of children.
Read enclosed leaflet before use

Dosage: As Directed by the Physician